New suction device aims to reduce stress in preterm infants

NCT ID NCT06443970

Recruiting now Symptom relief Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new FDA-approved suction device (EXSALTA) to standard suctioning in 30 preterm and term infants who are on breathing tubes. The goal is to see if the new device causes smaller changes in heart rate, oxygen levels, and brain oxygen levels during suctioning. Each baby will receive both methods in a random order, and researchers will monitor for episodes of slow heart rate or low oxygen.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Exsalta Suction Device
What this could lead to: If successful, this could lead to a gentler suctioning method for babies on breathing tubes, reducing stress on their heart and oxygen levels.
What could go wrong: This is a small, early-stage study with only 30 infants, so results may not apply to all babies. The new device may not show meaningful benefits over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RESPIRATORY FAILURE

Contacts and locations

Locations

Columbia University Irving Medical Center
RECRUITING

New York, New York, 10032-3720, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.